Repligen Corporation (RGEN) Q1 2018 Earnings Results

Repligen Corp Beats on EPS, Stock Up 5.66%

Repligen's earnings report shows a positive surprise in EPS, which contributed to a 5.66% increase in stock price. The management's comments about strong demand and innovation suggest a solid outlook for the company, although no specific guidance was given for future performance. Investors may view the earnings beat as a sign of resilience in a competitive market.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.17	N/A	+0.11%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed confidence in the company's position within the bioprocessing sector. They emphasized their commitment to innovation and customer satisfaction.

Management highlighted strong demand in the bioprocessing market.

They noted ongoing investments in innovation to drive future growth.

Repligen Corp Beats on EPS, Stock Up 5.66%

Key numbers

Management commentary

Repligen Corporation

More earnings this week

Repligen Corp Beats on EPS, Stock Up 5.66%

Key numbers

Management commentary